Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors

assignment_turned_inproject01 Jun 2021(Started)-31 May 2026(Ending)On going (M56)

Funder: National Institutes of HealthProject code: 5R01CA254110-04

Funded under: NATIONAL CANCER INSTITUTE Funder Contribution: 411,790 USD

Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors

- Summary
- DMPs

Partners

IU , IUPUI , Purdue University System

Data Management Plans

Start a new DMP in Argos

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=nih_________::dd5cdf927f6b8c27801e92b711080cce&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors

Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors

Loading